Gossamer Bio Investor Relations Material
Latest events
Collaboration with Chiesi Farmaceutici S.p.A. 2024
Gossamer Bio
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Gossamer Bio Inc
Access all reports
Gossamer Bio, Inc. is a U.S.-based biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in immunology, inflammation, and oncology. The company’s research pipeline targets diseases with unmet medical needs, including autoimmune disorders, inflammatory conditions, and cancer. Gossamer Bio leverages its scientific expertise to advance novel drug candidates through clinical trials, aiming to deliver effective treatment options for complex and chronic illnesses. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Key slides for Gossamer Bio Inc
Collaboration with Chiesi Farmaceutici S.p.A. 2024
Gossamer Bio Inc
Corporate Presentation 2024
Gossamer Bio Inc
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
GOSS
Country
🇺🇸 United States